SCHEMBL4034567

SCHEMBL4034567

Cc1cc2c(CCc3sc(-c4ccccc4C(F)(F)F)nc3C(C)C)noc2cc1N

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 5/20 0.53
PPARD Q03181 5/20 0.53
PPARA Q07869 5/20 0.53
PTPN1 P18031 1/20 0.33
ACHE P22303 1/20 0.32
USP1 O94782 2/20 0.32
WDR48 Q8TAF3 2/20 0.32
USP2 O75604 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
ALOX15 P16050 1/20 0.32
TSHR P16473 1/20 0.32
CYP2C19 P33261 1/20 0.32
HSD17B10 Q99714 1/20 0.32
CLK4 Q9HAZ1 1/20 0.32
EPHX2 P34913 1/20 0.31
DPP4 P27487 1/20 0.30
DPP7 Q9UHL4 1/20 0.30
S1PR1 P21453 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4033028 0.90 PPARG (0.54) PPARGPPARDPPARAACHEUSP1
SCHEMBL4030850 0.89 PPARG (0.50) PPARGPPARDPPARAPTPN1ACHE
SCHEMBL4030150 0.85 PPARG (0.52) PPARGPPARDPPARAACHEUSP1
SCHEMBL4034566 0.85 PPARD (0.70) PPARGPPARDPPARA
SCHEMBL4034202 0.85 PPARG (0.52) PPARGPPARDPPARAACHEEPHX2
SCHEMBL4028015 0.84 PPARG (0.54) PPARGPPARDPPARAACHECYP1A2
SCHEMBL3393036 0.83 PPARD (0.62) PPARGPPARDPPARACYP3A4ALOX15
SCHEMBL4025440 0.83 PPARA (0.77) PPARGPPARDPPARAACHE
SCHEMBL4024977 0.83 PPARD (0.54) PPARGPPARDPPARAUSP1WDR48
SCHEMBL4026350 0.83 PPARD (0.54) PPARGPPARDPPARAACHEDPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1445258-B1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DELTA NIPPON CHEMIPHAR CO (JP) 2009-06-24 EP disclosed
US-7402597-B2 Activator of peroxisome proliferator-activated receptor δ NIPPON CHEMIPHAR CO., LTD (JP) 2008-07-22 US disclosed
US-20070027196-A1 Activator of peroxisome proliferator-activated receptor delta SAKUMA SHOGO 2007-02-01 US disclosed
US-7119104-B2 Activator of peroxisome proliferator-activated receptor delta NIPPON CHEMIPHAR, CO., LTD. (JP) 2006-10-10 US disclosed
US-20050096363-A1 Activator of peroxisome proliferator-activated receptor delta NIPPON CHEMIPHAR CO., LTD. (JP) 2005-05-05 US disclosed
EP-1445258-A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DELTA NIPPON CHEMIPHAR CO., LTD. (JP) 2004-08-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070027196-A1 Activator of peroxisome proliferator-activated receptor delta PPARA, PPARG, PPARD PPARG 2/4885PPARD 3/4885PPARA 1/4885
US-20050096363-A1 Activator of peroxisome proliferator-activated receptor delta PPARA, PPARG, PPARD PPARG 2/4885PPARD 3/4885PPARA 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.